ArticleThe Journal of dermatology2022

Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance.

Hisashi Uhara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.